Leokadia Głogulska

Leokadia Głogulska

Leokadia Głogulska is a financial and technology journalist at TS2.tech. Her coverage ranges from stocks and artificial intelligence to space technology and developments across global markets. She graduated from Wrocław University of Economics and Business and worked in financial analysis before becoming a business journalist.

Fed Keeps Rates Unchanged; All Eyes on Warsh Debut

Fed Keeps Rates Unchanged; All Eyes on Warsh Debut

The Federal Reserve left rates steady Wednesday, holding the federal funds target at 3.50%-3.75%. It was Kevin Warsh’s first policy meeting as chair, and the changes were obvious—a briefer statement, no sign of an easing bias and a fresh rate outlook pointing to higher rates this year. The vote to keep rates unchanged was unanimous.
Outlook Therapeutics Stock Jumps as FDA Accepts Lytenava BLA, July Decision Looms

Outlook Therapeutics Stock Jumps as FDA Accepts Lytenava BLA, July Decision Looms

Outlook Therapeutics, Inc. stock surged Tuesday after the company said the U.S. Food and Drug Administration accepted its resubmitted Biologics License Application, or BLA, for ONS-5010/LYTENAVA as a treatment for wet age-related macular degeneration. A BLA is the FDA application used to seek approval to market a biologic medicine. OTLK traded at $1.51, up about 30.2% from its previous close of $1.16, with intraday volume above 33.7 million shares, according to market data available in afternoon trading.
Dow jumps to record as oil drops and Fed in focus

Dow jumps to record as oil drops and Fed in focus

Dow Jones climbed in morning trading Tuesday, advancing 360.77 points, or 0.70%, to 52,031.80, Reuters reported. The index set an intraday high with buyers moving into economically sensitive names after oil slipped on hopes tied to a preliminary U.S.-Iran peace agreement. The Dow, a price-weighted index tracked by S&P Dow Jones Indices, tracks 30 blue-chip U.S. stocks, with moves more affected by higher-priced shares.
Intel Holds Near Recent Highs After AI Run; Investors Watch Foundry Progress

Intel Holds Near Recent Highs After AI Run; Investors Watch Foundry Progress

Intel Corporation shares were mostly flat in early trade Tuesday, down 0.05% at $127.80, after chip stocks ran up on Monday. That keeps Intel’s market value near $649 billion. Tuesday’s small decline follows a sharp move higher in the group, as memory and data-storage names jumped and the Philadelphia Semiconductor Index set a new high, up more than 4%.
CervoMed Shares Rise in Early Trade After $3 Million Insider-Related Purchase

CervoMed Shares Rise in Early Trade After $3 Million Insider-Related Purchase

CervoMed Inc. shares spiked in premarket trading Tuesday, quoted around $3.30 after closing at $2.48 on Monday. The stock was up more than 30%, with MarketScreener and MT Newswires tying the jump to an SEC filing late Monday. The pop wasn’t about new clinical news. Instead, it followed a show of insider confidence: a Form 4 showed the Joshua S. Boger 2021 Trust bought 955,414 units at $3.14 apiece in a private placement, totaling about $3 million. Private placements are limited sales to select investors, not the public.
Opendoor Shares Edge Higher Ahead of Russell 3000 Change; Eyes on Q2 Profit Test

Opendoor Shares Edge Higher Ahead of Russell 3000 Change; Eyes on Q2 Profit Test

Opendoor Technologies Inc. gained 3.83% Monday, finishing the session at $4.61 after trading in a $4.57 to $4.825 range. Volume reached 46.5 million shares. Before Tuesday’s U.S. open, early quotes put the stock near $4.63. Stocks moved up in a risk-on day for U.S. markets, with Reuters saying futures on the Nasdaq and Dow were a bit higher as traders waited for the Federal Reserve rate call. Opendoor hasn’t issued a new press release, according to its investor relations site. The latest items there were June 15 Form 4 filings and a June 12 8-K related to its annual meeting.
16 June 2026
Shell Drops After Oil Slides and Buyback Halt Hits Sentiment

Shell Drops After Oil Slides and Buyback Halt Hits Sentiment

Shell Plc shares traded lower in London on Tuesday, still weighed down after a broad selloff in energy stocks and questions about its paused buyback programme. Hargreaves Lansdown quoted Shell at 3,070.50p to sell and 3,071.00p to buy, off by 10p, or 0.32%, on delayed data. The FTSE 100 was up 0.57%. On Monday, Shell fell 4.35% to finish at £30.81, lagging the FTSE 100’s 0.39% drop.
16 June 2026
1 28 29 30 31 32 40